An Act to establish a sharps stewardship program

1 of 1 HOUSE DOCKET, NO. 3387 FILED ON: 2/19/2021 HOUSE . . . . . . . . . . . . . . . No. 2403 The Commonwealth of Massachusetts _________________ PRESENTED BY: Jon Santiago _________________ To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act to establish a sharps stewardship program. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Jon Santiago 9th Suffolk 2/19/2021 Chynah Tyler 7th Suffolk 2/26/2021 James J. O'Day 14th Worcester 2/26/2021 Paul McMurtry 11th Norfolk 2/26/2021 1 of 2 HOUSE DOCKET, NO. 3387 FILED ON: 2/19/2021 HOUSE . . . . . . . . . . . . . . . No. 2403 By Mr. Santiago of Boston, a petition (accompanied by bill, House, No. 2403) of Jon Santiago and others relative to the definition of "covered drug" under the program financed by pharmaceutical product manufacturers or groups of manufacturers to collect, secure, transport and safely dispose of unwanted drugs. Public Health. The Commonwealth of Massachusetts _______________ In the One Hundred and Ninety-Second General Court (2021-2022) _______________ An Act to establish a sharps stewardship program. Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows: 1 SECTION 1. Section 1 of chapter 94H of the General Laws, as so appearing, is hereby 2 amended 3 by striking out the second paragraph and inserting in place thereof the following 4 paragraph:- 5 “Covered drug”, any brand name or generic opioid drug placed in Schedule II or 6 Schedule III of 7 section 3 of chapter 94C; provided, however, that “covered drug” shall also include 8 benzodiazepines; provided, further, that “covered drug” shall not include: (i) drugs 9 intended for 2 of 2 10 use solely in veterinary care; (ii) substances that are regulated as cosmetic products under 11 the 12 United States Food, Drug and Cosmetic Act, 21 U.S.C. § 301 et seq.; or (iii) drugs that 13 are 14 compounded under a specialty license pursuant to sections 39G to 39J, inclusive, of 15 chapter 112. 16 SECTION 2. Section 55 of chapter 52 of the acts of 2016, as amended by section 6 of 17 chapter 18 351 of the acts of 2016, is hereby repealed. 19 SECTION 3. Section 77 of chapter 52 of the acts of 2016, is hereby repealed.